Developments

Apology over missed Aids target / BBC News / 28.11.05
By Madeleine Morris / BBC News, Johannesburg

The head of the World Health Organisation's HIV/Aids programme has apologised for its failure to meet a global target for the treatment of HIV. It had aimed to get three million people in poor countries on Aids drugs by the end of this year, but the WHO admits that target will be missed. Three by Five, as it is known, was the much heralded programme to promote Aids treatment to the poorest of the poor. November 28, 2005

National Civil Society Consultation on The Global Fund
Approximately 40 civil society representatives from across India participated in a consultation to review the Global Fund in India, particularly in relation to the processes for involving civil society in decision-making, proposal development and implementation. Participants discussed and expressed their concerns over the level of participation of civil society in the Country Co-ordinating Mechanism (CCM), delays in implementation of Global Fund grants, limited availability of information on progress and the need for support and strategic co-ordination of civil society for proposal development.

A series of recommendations were made focusing on areas including CCM representation and communication, oversight of grant implementation, and proposal development. April 27, 2005

Public-Private 'Partnerships' in Health – A Global Call to Action
The need for public-private partnerships arose against the backdrop of inadequacies on the part of the public sector to provide public good on their own, in an efficient and effective manner, owing to lack of resources and management issues. Though such partnerships create a powerful mechanism for addressing difficult problems by leveraging on the strengths of different partners, they also package complex ethical and process-related challenges. This paper outlines key ethical and procedural issues inherent to different types of public-private arrangements and issues a Global Call to Action.
by Sania Nishtar, July 28, 2004

Public-Private Partnerships for Health: A Trend with No Alternatives?
The author argues that public–private partnerships are not necessarily positively innovative, but that many of them carry large risks that are neither highlighted nor addressed due
to the positive connotation of the term.
by Judith Richter, 2004

Analysis of Experience: The Role of Public Private Partnerships in HIV/AIDS Prevention, Control, and Treatment Programming, Part 1: Conceptual Framework
CSGOP-03-17 | Project Details
Muhiuddin Haider, Assistant Professor of Global Health, The George Washington University, March 2003

Analysis of Experience: The Role of Public Private Partnerships in HIV/AIDS Prevention, Control, and Treatment Programming, Part 2: Case Studies
CSGOP-03-18 | Project Details
Muhiuddin Haider, Assistant Professor of Global Health, The George Washington University, March 2003

Analysis of Experience: The Role of Public Private Partnerships in HIV/AIDS Prevention, Control, and Treatment Programming, Part 3: Lessons Learned
CSGOP-03-19 | Project Details
Muhiuddin Haider, Assistant Professor of Global Health, The George Washington University, March 2003

Codes in Context: TNC Regulation in an Era of Dialogues and Partnerships,
by Judith Richter, February 2002.

Greenwash + 10, The UN's Global Compact, Corporate Accountability and the Johannesburg Earth Summit
by Kenny Bruno, Corpwatch, Alliance for a Corporate-Free UN, January 24, 2002.

New Products into Old Systems, The initial impact of the Global Alliance for Vaccines and Immunization (GAVI) at country level. By London School of Hygiene and Tropical Medicine (Mary Starling, Ruairi, Brugha and Gill Walt), with contributions from Save the Children UK (Annie Heaton and Regina Keith).

Unhealthy Influence, there is a danger that WHO's new partnership with drug companies will skew its health policies, by Sarah Boseley, The Guardian, February 6, 2002.